Skip to content

Norwegian Translation of the Things You Do Questionnaire 15-Item Version

A Translation Study of the Things You Do Questionnaire 15-Item Version

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06908525
Acronym
TYDQ-15
Enrollment
1000
Registered
2025-04-03
Start date
2025-03-24
Completion date
2027-02-01
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age 16 and Older, General Adult Population

Keywords

Translation, TYDQ-15, Psychometric Evaluation

Brief summary

Psychotherapy aims to modify dysfunctional patterns of thinking, feeling, and behaving to improve mental health. A five-factor model of adaptive behaviors, operationalized in the Things You Do Questionnaire (TYDQ), has been identified as a mediator of treatment response in depression and anxiety interventions. The short-form TYDQ-15 is a key component of a transdiagnostic treatment promoting adaptive behavior. To implement this intervention in Norway, the TYDQ-15 requires translation and cultural adaptation, following established guidelines for clinical assessment instruments. Currently unavailable in Norwegian, its translation and psychometric evaluation are necessary for clinical application. This study aims to (1) produce a culturally adapted Norwegian version of the TYDQ-15 and (2) assess its psychometric properties, including reliability, factor structure, and criterion validity, within a Norwegian population. The findings will facilitate the integration of the Things You Do Intervention into Norwegian mental health services.

Interventions

None listed

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Age \> 16 years * Native Norwegian speaker

Exclusion criteria

* Does not speak Norwegian fluently

Design outcomes

Primary

MeasureTime frameDescription
Things You Do Questionnaire 15-Item Version (TYDQ-15)Singe time point, at enrolment.The Things You Do Questionnaire - 15 Item Version (TYDQ-15) measures how frequently one engages in adaptive behavior with 15 items scored 0 (never) to 4 (every day). The 15 items are grouped into the five domains of meaningful activities, healthy thinking, goals and plans, healthy routines, and social connections. The original English language instrument has been shown to have acceptable psychometric properties across representative population samples.

Secondary

MeasureTime frameDescription
The Patient Health Questionnaire (PHQ-9)Single time point, at enrolment.The Patient Health Questionnaire (PHQ-9) - measures depression severity with nine items scored 0 (not at all) to 3 (nearly every day), corresponding to the criteria for major depression in the DSM-5. The sum of the nine items ranges from 0-27. The scale has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to change in depressive symptoms.
The Generalized Anxiety Disorder Scale (GAD-7)Single time point, at enrolment.The Generalized Anxiety Disorder Scale (GAD-7) - measures anxiety severity with seven items scored 0 (not at all) to 3 (nearly every day) corresponding to symptoms of anxiety disorders. The sum score ranges from 0-21. GAD-7 has demonstrated adequate psychometric properties across different samples and has been found to be sensitive to the presence of anxiety disorders.
The Satisfaction with Life Scale (SWLS)Single time point, at enrolment.The Satisfaction with Life Scale (SWLS) - measures life-satisfaction with 5 items scored 1 (strongly disagree) to 7 (strongly agree), corresponding to statements of general life satisfaction. Sum scores range from X to Y with higher scores indicating greater life satisfaction. The SWLS has demonstrated adequate psychometric properties across different samples.

Contacts

Primary ContactAleksander G Heltne, PhD
aleksander.gulla.heltne@helse-bergen.no00000000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026